Scientists at ETH Zurich have broken new ground by generating over 400 types of nerve cells from stem cells in the lab, far ...

New development at the University of Sheffield will double the research capacity of the world-leading research facility, ...

Bricklaying ceremony marks major milestone for the expansion of Sheffield Institute for Translational Neuroscience (SITraN) ...

Researchers have created over 400 distinct types of human nerve cells in vitro, vastly expanding the diversity available for ...

Research indicates that neural stem cell transplants could promote myelin repair in progressive multiple sclerosis, paving the way for innovative treatments.

An annual University of Sheffield charity walk has raised tens of thousands for neurological disease research. Earlier today ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Over 400 members of staff, students and friends of the University of Sheffield donned their walking boots today (Friday 27 June 2025) and set off on a hike across the picturesque Peak District to ...

New research sheds light on the mechanisms of degeneration in multiple sclerosis, suggesting that mitochondrial dysfunction may play a key role in the loss of neuronal Purkinje cells.

Updates in safety, efficacy, and specificity may make switching treatments beneficial for people with secondary progressive multiple sclerosis (SPMS). Learn more.

Neuron23 has announced the publication of a manuscript in PNAS exploring the role of TYK2 inhibition in multiple sclerosis (MS) and neuroinflammation.